Clinical Trial Update: Subcutaneous Immunoglobulin Treatment of Patients With Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP) [Phase 2]

View source ↗

Summary

This document indicates the completion of a Phase 2 clinical trial assessing subcutaneous immunoglobulin treatment for chronic inflammatory demyelinating polyne…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Inflammatory Demyelinating Polyneuropathy

Drugs mentioned

• Subcutaneous immunoglobulin (immunoglobulin)

Snippet

Sponsor: University of Aarhus | Conditions: Polyradiculoneuropathy, Chronic Inflammatory Demyelinating | Phase 2 | Status: COMPLETED